美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Phendimetrazine Tartrate	Capsule (Extended Release)	II (Paddle)	50	1 hour - SGF w/o Enzymes; after 1 hour - SIF w/o Enzymes	900	1, 2, 4, 6 and 8 hours	2009/06/10
Phenelzine Sulfate	Tablet	II (Paddle)	50	Simulated Gastric Fluid without enzymes, pH 1.2	900	10, 20, 30 and 45	2010/03/25
Phenoxybenzamine HCl	Capsule			Refer to USP			2008/04/10
Phentermine HCl	Tablet (Orally Disintegrating)			Develop a dissolution method			2023/09/15
Phentermine HCl	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Phentermine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Phentermine HCl/Topiramate	Capsule (Extended Release)			Develop a dissolution method			2023/09/15
Phenytoin	Suspension			Refer to USP			2007/06/18
Phenytoin	Tablet (Chewable)			Develop a dissolution method			2024/01/03
Phenytoin Sodium	Capsule			Develop a dissolution method			2024/01/03
Phytonadione	Tablet			Develop a dissolution method			2010/03/25
Pilocarpine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Pimavanserin Tartrate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Pimozide	Tablet			Refer to USP			2008/02/19
Pindolol	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Pioglitazone HCl	Tablet	II (Paddle)	75	HCl-0.3 M KCl Buffer, pH 2.0	900	5, 10, 15 and 30	2004/02/13
Pirfenidone	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Pirfenidone	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Piroxicam	Capsule			Refer to USP			2012/10/04
Pirtobrutinib	Tablet	II (Paddle)	75	Sodium Phosphate Buffer, pH 6.8	900	5, 10, 15, 20, 30, 45 and 60	2024/05/31